Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(24)00381-4
Publication URI: http://dx.doi.org/10.1016/s2214-109x(24)00381-4
Type: Journal Article/Review
Parent Publication: The Lancet Global Health
Issue: 12